Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(e) On May 10, 2012, the Board of Directors of Alexza Pharmaceuticals, Inc. (the
"Company") granted 100,000 restricted stock units (the "RSUs") to each of Thomas
B. King, James V. Cassella, Michael J. Simms and Mark K. Oki (the "Executive
Officers"). The RSUs were granted under and in accordance with the terms and
conditions of the Company's 2005 Equity Incentive Plan and the Form of Notice of
Grant of Award and Stock Unit Award Agreement previously filed with the
Securities and Exchange Commission. The RSUs will vest in full on August 24,
2012, provided that the Executive Officer remains employed by the Company
through such date.
Add
ALXA to Portfolio
Set Alert
Email to a
Friend